Skip to main content

Advertisement

Table 3 Cure Rates by Monomicrobial/Polymicrobial Infection at the Test-of-Cure Visit

From: Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

  Tigecycline Levofloxacin Difference (Tigecycline -- Levofloxacin)
  n/N % (95% CI) n/N % (95% CI) % (95% CI)
ME      
   Monomicrobial 53/58 91.4 (81.0, 97.1) 56/64 87.5 (76.8, 94.4) 3.9 (-9.0, 16.3)
   Polymicrobial 25/28 89.3 (71.8, 97.7) 20/21 95.2 (76.2, 99.9) -6.0 (-25.1, 16.6)
m-mITT      
   Monomicrobial 74/84 88.1 (79.2, 94.1) 76/88 86.4 (77.4, 92.8) 1.7 (-9.4, 12.7)
   Polymicrobial 28/34 82.4 (65.5, 93.2) 23/25 92.0 (74.0, 99.0) -9.6 (-28.4, 12.4)
  1. ME = microbiologically evaluable population; m-mITT = microbiologic-modified intent-to-treat population.